Proyecto de Investigación
Proiektua DGU.PROY.17
ProID2017010094. Desarrollo de nuevos medicamentos para el tratamiento de la tuberculosis pediátrica: formas farmacéuticas de administración oral.
date_range
Iraupena 2017(e)ko iraila-(a)k 15-(e)tik 2021(e)ko apirila-(a)k 30-(e)ra izan da
(43 months)
Amaitu
Norgehiagoka-aren araubidean eman da.
Deialdi:
PI.ACIISI.17.02.06
Ikertzaileak
(5) proiektuarekin lotutako argitalpenak
Erakutsi urterokoaren araberaArtikulua
-
Impact of storage conditions on a new child-friendly dispersible tablet for treating Tuberculosis in pediatrics.
2021
Pharmaceutical Sciences
-
Design and optimization of a child-friendly dispersible tablet containing isoniazid, pyrazinamide, and rifampicin for treating tuberculosis in pediatrics
2020
Drug Development and Industrial Pharmacy
-
Stability study of isoniazid and rifampicin oral solutions using hydroxypropyl-Β-cyclodextrin to treat tuberculosis in paediatrics
2020
Pharmaceutics
-
A High-Demanding Strategy to Ensure the Highest Quality Standards of Oral Liquid Individualized Medicines for Pediatric Use
2019
AAPS PharmSciTech
Tesia
-
Desarrollo y caracterización de formulaciones farmacéuticas adaptadas para pediatría
2020
Suárez González, Javier